URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Michael Schell

Concepts (268)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Radiosurgery
17
1994
74
3.170
Why?
Brachytherapy
20
1985
111
2.060
Why?
Brain Neoplasms
9
1997
282
1.270
Why?
Radiotherapy Dosage
27
1979
203
0.980
Why?
Radiotherapy Planning, Computer-Assisted
10
1987
48
0.720
Why?
Central Nervous System
1
2011
117
0.720
Why?
Lung Neoplasms
7
1994
428
0.680
Why?
Radiotherapy
5
1990
198
0.610
Why?
Iodine Radioisotopes
9
1985
103
0.590
Why?
Prostatic Neoplasms
8
1985
556
0.540
Why?
Carcinoma, Squamous Cell
2
1984
232
0.500
Why?
Radiometry
5
1982
40
0.470
Why?
Dose Fractionation
6
2001
58
0.460
Why?
Adenocarcinoma
1
2006
423
0.430
Why?
Stents
3
1999
123
0.410
Why?
Fast Neutrons
8
1979
10
0.370
Why?
Humans
57
1979
36400
0.370
Why?
Beta Particles
1
1999
6
0.360
Why?
Algorithms
4
1996
537
0.350
Why?
Neutrons
5
1979
8
0.350
Why?
Coronary Vessels
2
1999
135
0.340
Why?
Blood Vessels
1
1999
91
0.320
Why?
Radiotherapy, High-Energy
6
1980
24
0.310
Why?
Ear Neoplasms
1
1996
6
0.300
Why?
Professional Staff Committees
3
2001
6
0.290
Why?
Neurilemmoma
1
1996
20
0.290
Why?
Radiation Oncology
3
2001
18
0.290
Why?
Pancreatic Neoplasms
2
1991
84
0.290
Why?
Particle Accelerators
5
1982
13
0.290
Why?
Aged, 80 and over
10
2002
2513
0.280
Why?
Vestibule, Labyrinth
1
1996
82
0.270
Why?
Pituitary Neoplasms
1
1995
66
0.260
Why?
Tunica Intima
3
1998
92
0.250
Why?
Male
29
1982
19713
0.250
Why?
Research Design
3
2001
333
0.240
Why?
Middle Aged
16
1982
9877
0.240
Why?
Brain Diseases
2
1990
134
0.230
Why?
Aged
15
1982
7272
0.230
Why?
Radiotherapy, Computer-Assisted
3
1987
15
0.220
Why?
Treatment Outcome
8
2001
2623
0.220
Why?
Feasibility Studies
4
1999
205
0.220
Why?
Stereotaxic Techniques
2
1990
33
0.210
Why?
Glioblastoma
3
1982
63
0.210
Why?
Chemoprevention
1
2011
12
0.210
Why?
Neoplasms
4
1979
723
0.200
Why?
Radiation Dosage
5
1979
126
0.190
Why?
Vascular Surgical Procedures
2
2000
68
0.190
Why?
Adult
15
1982
11345
0.190
Why?
Neoplasm Metastasis
2
2008
229
0.180
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2003
430
0.180
Why?
Patient Selection
1
2011
209
0.180
Why?
Treatment Failure
2
2006
130
0.170
Why?
Thoracic Neoplasms
1
2009
19
0.170
Why?
Liver Neoplasms
2
2006
152
0.170
Why?
Mathematics
2
1979
149
0.170
Why?
Carotid Stenosis
2
1999
49
0.160
Why?
Female
20
1982
19826
0.160
Why?
Monte Carlo Method
4
1987
57
0.160
Why?
Tomography, X-Ray Computed
5
1987
765
0.160
Why?
Practice Guidelines as Topic
1
2010
304
0.150
Why?
Survival Analysis
2
2006
598
0.150
Why?
Glioma
1
2008
102
0.150
Why?
Muscle, Smooth, Vascular
2
2000
377
0.150
Why?
Paclitaxel
2
2003
57
0.140
Why?
Cisplatin
2
2003
94
0.140
Why?
Antineoplastic Protocols
1
2006
3
0.140
Why?
Hyperplasia
6
1998
94
0.140
Why?
Magnetic Resonance Imaging
4
1996
1010
0.140
Why?
Antineoplastic Agents
1
2011
625
0.130
Why?
Retrospective Studies
5
2006
2260
0.130
Why?
Prochlorperazine
1
2005
11
0.130
Why?
Ondansetron
1
2005
11
0.130
Why?
Biophysical Phenomena
4
1994
52
0.130
Why?
Radiotherapy, Conformal
2
2001
19
0.130
Why?
Biophysics
4
1994
61
0.130
Why?
Dose-Response Relationship, Radiation
8
1980
218
0.130
Why?
Antiemetics
1
2005
56
0.130
Why?
Decision Theory
3
1997
7
0.120
Why?
Vomiting
1
2005
116
0.120
Why?
Postoperative Care
1
2004
129
0.120
Why?
Film Dosimetry
3
1979
6
0.120
Why?
Dexamethasone
1
2005
183
0.120
Why?
Palladium
3
1996
15
0.120
Why?
Models, Structural
4
1987
53
0.120
Why?
Nausea
1
2005
155
0.120
Why?
Ifosfamide
1
2003
8
0.110
Why?
Catheterization
3
1998
127
0.110
Why?
Photogrammetry
1
2003
3
0.110
Why?
Carcinoma, Small Cell
1
2003
32
0.110
Why?
Radiation Protection
3
1987
23
0.110
Why?
Immobilization
1
2003
28
0.110
Why?
Peripheral Vascular Diseases
1
2002
28
0.110
Why?
United States
4
1999
2630
0.110
Why?
Imaging, Three-Dimensional
1
2003
85
0.100
Why?
Radiation Injuries
5
1984
130
0.100
Why?
Blood Vessel Prosthesis Implantation
1
2001
50
0.100
Why?
Image Enhancement
1
2003
146
0.100
Why?
Breast Neoplasms
2
2004
675
0.100
Why?
Radioisotopes
2
1996
51
0.100
Why?
Carotid Arteries
2
1998
106
0.100
Why?
Prostatic Diseases
1
2000
9
0.090
Why?
Cobalt Radioisotopes
2
1979
17
0.090
Why?
Computer Simulation
2
1999
298
0.090
Why?
Models, Biological
3
1990
1023
0.090
Why?
Models, Theoretical
4
1979
189
0.090
Why?
Calibration
1
1999
43
0.090
Why?
Intracranial Arteriovenous Malformations
1
1999
15
0.090
Why?
Models, Genetic
2
1996
160
0.090
Why?
Tantalum
1
1999
5
0.090
Why?
Vascular Diseases
1
2000
70
0.090
Why?
Alloys
1
1999
17
0.090
Why?
X-Rays
1
1999
28
0.090
Why?
Nickel
1
1999
24
0.090
Why?
Survival Rate
3
2003
619
0.090
Why?
Technology, Radiologic
1
1979
17
0.090
Why?
Graft Occlusion, Vascular
1
1999
24
0.080
Why?
Energy Transfer
2
1987
29
0.080
Why?
Ultrasonography, Interventional
1
1999
66
0.080
Why?
Angioplasty, Balloon, Coronary
1
1999
68
0.080
Why?
Titanium
1
1999
139
0.080
Why?
Kaplan-Meier Estimate
2
2008
224
0.080
Why?
Coronary Artery Disease
1
1999
96
0.080
Why?
Prognosis
4
1980
1080
0.080
Why?
Pilot Projects
3
1980
441
0.080
Why?
Platelet-Derived Growth Factor
1
1998
115
0.080
Why?
Uterine Cervical Neoplasms
2
1987
124
0.070
Why?
Coronary Disease
1
1999
266
0.070
Why?
Quality Assurance, Health Care
1
1998
119
0.070
Why?
Orbital Neoplasms
2
1985
25
0.070
Why?
Animals
9
1987
16270
0.070
Why?
Image Processing, Computer-Assisted
1
1998
262
0.070
Why?
Radiographic Image Enhancement
1
1996
60
0.070
Why?
Double-Blind Method
2
2005
998
0.070
Why?
Macrophages
1
1998
347
0.070
Why?
Iridium Radioisotopes
2
1989
15
0.070
Why?
Lymphoma
2
1985
163
0.060
Why?
Neoplasm Staging
2
2003
335
0.060
Why?
Radiography
1
1994
17
0.060
Why?
Phantoms, Imaging
3
1996
145
0.060
Why?
Plastics
3
1982
13
0.060
Why?
Lung
3
1987
1142
0.060
Why?
Multivariate Analysis
2
2004
531
0.060
Why?
Rectum
2
1987
56
0.060
Why?
Head and Neck Neoplasms
1
1994
84
0.060
Why?
Spinal Cord
1
1994
164
0.060
Why?
Bone Neoplasms
2
1980
206
0.060
Why?
Cell Survival
3
1987
561
0.050
Why?
Duodenum
1
1991
33
0.050
Why?
Connective Tissue
1
1991
43
0.050
Why?
Amifostine
1
1991
28
0.050
Why?
Follow-Up Studies
2
1999
1857
0.050
Why?
Quality Control
2
2000
69
0.050
Why?
Cholelithiasis
1
1991
13
0.050
Why?
Electrons
2
1982
12
0.050
Why?
Rats, Sprague-Dawley
3
1998
1028
0.050
Why?
Organizational Objectives
2
2001
27
0.050
Why?
Bone and Bones
2
1990
357
0.050
Why?
Neoplasm Recurrence, Local
3
1980
286
0.050
Why?
Biopsy
1
2011
359
0.050
Why?
Graphite
1
1990
2
0.050
Why?
Forecasting
2
2001
178
0.050
Why?
Combined Modality Therapy
2
1999
486
0.050
Why?
Intraoperative Period
2
1999
46
0.040
Why?
Bromodeoxyuridine
1
1989
67
0.040
Why?
Carotid Artery Injuries
2
1998
26
0.040
Why?
Equipment Design
1
1990
247
0.040
Why?
Salvage Therapy
1
2009
60
0.040
Why?
Disease-Free Survival
1
2009
202
0.040
Why?
Radiation-Sensitizing Agents
1
1989
72
0.040
Why?
Diagnosis, Differential
1
2011
878
0.040
Why?
Necrosis
3
1980
105
0.040
Why?
Radiochemistry
1
1987
4
0.040
Why?
Misonidazole
1
1987
9
0.040
Why?
Nitroimidazoles
1
1987
11
0.040
Why?
Urinary Bladder
1
1987
74
0.040
Why?
Comorbidity
1
2009
374
0.040
Why?
Time Factors
4
1980
3201
0.040
Why?
Disease Progression
1
2009
519
0.040
Why?
Remission Induction
1
2006
163
0.040
Why?
Recurrence
2
1998
697
0.040
Why?
Rats
3
1998
4386
0.040
Why?
Clinical Trials as Topic
2
1999
675
0.030
Why?
Serotonin Antagonists
1
2005
21
0.030
Why?
Carboplatin
1
2005
30
0.030
Why?
Cyclophosphamide
1
2005
173
0.030
Why?
Doxorubicin
1
2005
109
0.030
Why?
Pharyngeal Neoplasms
1
1984
7
0.030
Why?
Mouth Neoplasms
1
1984
34
0.030
Why?
Robotics
1
2005
75
0.030
Why?
Subtraction Technique
1
2003
10
0.030
Why?
Taxoids
1
2003
13
0.030
Why?
Prospective Studies
1
2008
1677
0.030
Why?
Motion
1
2003
43
0.030
Why?
Patient Satisfaction
1
2005
230
0.030
Why?
Anastomosis, Surgical
1
2002
64
0.030
Why?
Optics and Photonics
1
2003
43
0.030
Why?
Scattering, Radiation
2
1979
75
0.030
Why?
Posture
1
2003
113
0.030
Why?
Radiation Tolerance
1
2002
89
0.030
Why?
Evaluation Studies as Topic
2
1980
243
0.030
Why?
Sheep
1
2001
96
0.030
Why?
Respiration
1
2002
181
0.030
Why?
Polytetrafluoroethylene
1
2001
39
0.030
Why?
Vascular Patency
1
2001
68
0.030
Why?
Physics
1
2001
6
0.020
Why?
Physical Phenomena
1
2001
6
0.020
Why?
Movement
1
2002
165
0.020
Why?
Decision Making, Computer-Assisted
1
2000
13
0.020
Why?
Thermoluminescent Dosimetry
2
1989
4
0.020
Why?
Artificial Intelligence
1
2000
23
0.020
Why?
Diagnostic Imaging
1
2001
86
0.020
Why?
Interprofessional Relations
1
2001
75
0.020
Why?
Soft Tissue Neoplasms
1
1980
46
0.020
Why?
Muscles
2
1990
348
0.020
Why?
Pubic Bone
1
1999
8
0.020
Why?
Sarcoma
1
1980
63
0.020
Why?
Urethra
1
1999
50
0.020
Why?
Angioplasty, Balloon
1
2000
72
0.020
Why?
Arteriosclerosis
1
2000
95
0.020
Why?
Radiology
1
1999
29
0.020
Why?
Radiopharmaceuticals
1
1999
49
0.020
Why?
Child, Preschool
2
1991
2612
0.020
Why?
Cerebral Hemorrhage
1
1999
60
0.020
Why?
Computers
1
1979
81
0.020
Why?
Quality of Life
1
2003
509
0.020
Why?
Risk Factors
2
1991
2318
0.020
Why?
Cranial Irradiation
1
1998
12
0.020
Why?
Dose-Response Relationship, Drug
1
2001
1138
0.020
Why?
Prostate
1
1999
204
0.020
Why?
Disease Models, Animal
1
2001
973
0.020
Why?
Child
2
1991
4086
0.020
Why?
Analysis of Variance
1
1999
725
0.020
Why?
Cell Adhesion
1
1998
272
0.020
Why?
Probability
1
1997
294
0.020
Why?
Observer Variation
1
1996
143
0.020
Why?
Adolescent
2
1991
4752
0.020
Why?
Cell Line
2
1989
1594
0.020
Why?
Cell Division
1
1998
766
0.020
Why?
Cell Movement
1
1998
376
0.020
Why?
Mediastinum
1
1994
18
0.020
Why?
Photons
1
1994
19
0.020
Why?
Gases
2
1982
36
0.010
Why?
Urinary Diversion
1
1991
15
0.010
Why?
Parenteral Nutrition
1
1991
23
0.010
Why?
Brain
1
1999
1221
0.010
Why?
Cells, Cultured
2
1987
2563
0.010
Why?
Ileum
1
1991
53
0.010
Why?
Dogs
1
1991
488
0.010
Why?
Mathematical Computing
1
1990
12
0.010
Why?
Breast
1
1990
65
0.010
Why?
Surgical Procedures, Operative
1
1990
114
0.010
Why?
Interphase
1
1989
36
0.010
Why?
Etanidazole
1
1987
24
0.010
Why?
Methods
1
1987
220
0.010
Why?
Cricetulus
1
1987
97
0.010
Why?
Cricetinae
1
1987
389
0.010
Why?
Regression Analysis
1
1987
524
0.010
Why?
Infant
1
1991
2249
0.010
Why?
Oropharynx
1
1984
11
0.010
Why?
Neck
1
1984
34
0.010
Why?
Lymphatic Metastasis
1
1984
136
0.010
Why?
Gamma Rays
1
1982
69
0.010
Why?
Magnetics
1
1982
37
0.010
Why?
Osteoradionecrosis
1
1980
3
0.010
Why?
Mucous Membrane
1
1980
36
0.010
Why?
Gastrointestinal Diseases
1
1980
36
0.010
Why?
Central Nervous System Diseases
1
1980
57
0.010
Why?
Skin Diseases
1
1980
119
0.010
Why?

Visualizations


Schell's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department